SG11201809811VA - Compositions and methods for treatment of inflammation or infection of the eye - Google Patents

Compositions and methods for treatment of inflammation or infection of the eye

Info

Publication number
SG11201809811VA
SG11201809811VA SG11201809811VA SG11201809811VA SG11201809811VA SG 11201809811V A SG11201809811V A SG 11201809811VA SG 11201809811V A SG11201809811V A SG 11201809811VA SG 11201809811V A SG11201809811V A SG 11201809811VA SG 11201809811V A SG11201809811V A SG 11201809811VA
Authority
SG
Singapore
Prior art keywords
inflammation
infection
eye
compositions
treatment
Prior art date
Application number
SG11201809811VA
Inventor
Joseph Capriotti
Kara Capriotti
Jesse Pelletier
Original Assignee
Veloce Biopharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veloce Biopharma Llc filed Critical Veloce Biopharma Llc
Publication of SG11201809811VA publication Critical patent/SG11201809811VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201809811VA 2016-05-05 2017-05-05 Compositions and methods for treatment of inflammation or infection of the eye SG11201809811VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662332306P 2016-05-05 2016-05-05
PCT/US2017/031390 WO2017193060A1 (en) 2016-05-05 2017-05-05 Compositions and methods for treatment of inflammation or infection of the eye

Publications (1)

Publication Number Publication Date
SG11201809811VA true SG11201809811VA (en) 2018-12-28

Family

ID=60203517

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201809811VA SG11201809811VA (en) 2016-05-05 2017-05-05 Compositions and methods for treatment of inflammation or infection of the eye

Country Status (10)

Country Link
US (1) US20190160003A1 (en)
EP (1) EP3452015A4 (en)
KR (1) KR20190005179A (en)
CN (1) CN109475496A (en)
BR (1) BR112018072664A2 (en)
CA (1) CA3023259A1 (en)
MX (1) MX2018013507A (en)
PH (1) PH12018502318A1 (en)
SG (1) SG11201809811VA (en)
WO (1) WO2017193060A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210213045A1 (en) * 2017-11-20 2021-07-15 Veloce Biopharma Llc Novel ophthalmic composition and methods of use
WO2019135779A1 (en) * 2018-01-08 2019-07-11 Veloce Biopharma, Llc Novel ophthalmic composition and methods of use
NL2025640B1 (en) * 2020-04-17 2023-05-15 Veloce Biopharma Llc Methods and composition for improved antisepsis
CN114216993B (en) * 2021-12-27 2024-01-23 诺峰药业(成都)有限公司 Detection method of prednisolone acetate eye drops related substances

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556848A (en) * 1993-12-27 1996-09-17 Senju Pharmaceutical Co., Ltd. Ophthalmic suspension containing diflupredonate
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
US20110319805A1 (en) * 2010-06-29 2011-12-29 Bryan Knicely Morris Topical composition for treating the skin
PE20141070A1 (en) * 2011-05-12 2014-09-14 Foresigth Biotherapeutics Inc STABLE POVIDONE IODINE COMPOSITIONS WITH STEROID OR NON-STEROID ANTI-INFLAMMATORY
GB201114725D0 (en) * 2011-08-25 2011-10-12 Altacor Ltd Ophthalmic formulations
US20140273525A1 (en) * 2013-03-13 2014-09-18 Intermolecular, Inc. Atomic Layer Deposition of Reduced-Leakage Post-Transition Metal Oxide Films
EP3016634A2 (en) * 2013-07-05 2016-05-11 Therakine Biodelivery GmbH Drug-delivery composition for topical applications and injections and ophtalmic formulations, method for manufacturing thereof, and methods for delivery a drug-delivery composition

Also Published As

Publication number Publication date
EP3452015A1 (en) 2019-03-13
US20190160003A1 (en) 2019-05-30
CA3023259A1 (en) 2017-11-09
KR20190005179A (en) 2019-01-15
EP3452015A4 (en) 2019-12-11
CN109475496A (en) 2019-03-15
WO2017193060A1 (en) 2017-11-09
MX2018013507A (en) 2019-09-11
BR112018072664A2 (en) 2019-02-19
PH12018502318A1 (en) 2019-04-15

Similar Documents

Publication Publication Date Title
EP3347469A4 (en) Methods and compositions for the treatment of glaucoma
EP3390634A4 (en) Compositions and methods for treatment of eye diseases
IL273959A (en) Methods and compositions for the treatment of rare diseases
PL3448421T3 (en) Methods and compositions for the prevention and treatment of surgical adhesions
ZA202002066B (en) Compositions and methods for the treatment of eye disorders
HK1249515A1 (en) Methods and compositions for the prevention and treatment of hearing loss
ZA201702884B (en) Compositions and methods for the treatment and prophylaxis of surgical site infections
EP3280422A4 (en) Compositions and methods for the treatment of hbv infection
ZA201902781B (en) Compositions and methods for the treatment of xerostomia
EP3429584A4 (en) Compositions and methods for the treatment of presbyopia
HK1252343A1 (en) Compositions and methods for the treatment of viral infection
IL272121A (en) Composition and methods for the treatment of myopia
SG11201809811VA (en) Compositions and methods for treatment of inflammation or infection of the eye
SG11201705524SA (en) Compositions and methods for the treatment of inflammation and pain
ZA201907487B (en) Compositions and treatment procedures for the treatment of pathogenic infections
EP3341006A4 (en) Compositions and methods for the treatment of neurodamage
ZA201900984B (en) Methods and compositions for the treatment of warts
EP3706767A4 (en) Compositions and methods for the treatment of allergy
EP3518951A4 (en) Compositions and methods for the treatment of orthopedic ailments
GB201621737D0 (en) Compositions and methods of treatment
EP3554494A4 (en) Compositions and methods for the treatment of inflammation
EP3362085A4 (en) Compositions and methods for the treatment of diseases involving mucin
GB201605127D0 (en) Composition and methods of treatment
EP3668836A4 (en) Compositions for the treatment of dry eye and methods of use thereof
EP3277088A4 (en) Nanoparticle compositions and methods for treating or preventing tissue infections and diseases